Thats why clinicians usually recommend evaluating progress after staying on a dose for a while
Physical Signs of damage due to vomiting including swelling around the cheeks or jaw, calluses on knuckles, damage to teeth and bad breath Feeling bloated, constipated or developing intolerances to food Loss of or disturbance to menstruation Fainting or dizziness Fatigue or lethargy Sleep disturbances Compromised immune system (e.g., getting sick more often) Sudden weight loss, gain or fluctuation Psychological Preoccupation with eating, food, body shape and weight Intense fear of gaining weight Preoccupation with food or activities relating to food Heightened anxiety or irritability around mealtimes Heightened sensitivity to comments or criticism (real or perceived) about body shape or weight, eating or exercise habits Low self-esteem and feelings of shame, self-loathing or guilt Body dissatisfaction and negative body image Depression, anxiety, self-harm or suicidality Obsession with food and need for control Behavioural Repetitive dieting behaviour such as counting calories, skipping meals, fasting or avoidance of certain foods or food groups Evidence of binge eating such as disappearance or hoarding of food Evidence of vomiting or misuse of laxatives, appetite suppressants, enemas and/or diuretics Frequent trips to the bathroom during or shortly after meals Patterns or obsessive rituals around food, food preparation and eating Avoidance of, or change in behaviour in social situations involving food Social withdrawal or isolation from friends and family Secretive behaviour around eating Compulsive or excessive exercising Substance misuse Inappropriate hydration behaviours It is never advised to watch and wait
We framed obesity as a failure of willpower
GLP-1 receptor agonists should only be prescribed according to their licensed indications and NICE-approved criteria, following comprehensive assessment by a qualified healthcare professional
